Volume 9, Number 4—April 2003
Research
Costs of Illness in the 1993 Waterborne Cryptosporidium Outbreak, Milwaukee, Wisconsin
Table 1
Parameter | Mild illnessa | Moderate illness | Severe illness |
---|---|---|---|
% of infected persons with diarrhea |
87.99 (6) |
10.92 (6) |
1.09 (6) |
Medical costs |
|||
Inpatient healthcare costs |
|||
% with hospitalization |
100 |
||
Cost of hospitalization |
– |
– |
$6,312b |
Outpatient healthcare costs |
|||
% with physician visit |
95c |
29b |
|
Cost of physician visit |
– |
$45d |
$45d |
% with emergency department visit |
5b |
||
Cost of emergency department visit |
– |
$224b |
|
Ambulance transport |
|||
% of emergency department visit/hospitalization with ambulance transport |
– |
4.9b |
16.3b |
Cost of ambulance transport |
– |
$228 (11)c |
$228 (11)c |
Medication |
|||
Self-medication before seeking healthcare |
|||
Duration of illness before seeking health care, mean days |
4.7e |
5.8b |
18.4b |
% taking medication |
30c |
30b |
29b |
Cost of medication |
$5.73 (12)c |
$5.92 (12)c |
$6.74 (12)b |
Medication prescribed after seeking healthcare |
|||
% taking medication |
— |
54b |
48b |
Cost of medication |
$8.91 (12)b |
$70.52 (12)b |
|
Recurrent episodes |
|||
% with recurrent episodes (and assuming 100% take medication) |
21 (7) |
21 (7) |
21 (7) |
Duration of recurrent episodes, mean d |
2 (8) |
2 (8) |
2 (8) |
Cost of medication |
$2.44 (12)c |
$2.44 (12)c |
$2.44 (12)c |
Productivity losses |
|||
Productivity losses for ill persons, mean d |
1.3e |
3.8e |
13.5e |
Productivity losses for caregivers, mean d |
0.1e |
1.3e |
3.9c |
Earnings lost/d | $81 (13) | $81 (13) | $81 (13) |
aReference nos. are in parentheses.
bMedical chart review.
cAuthor assumption.
dCity of Milwaukee Health Department.
eRandom digit dial survey conducted by the City of Milwaukee Health Department.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.